Advertisement Pinnacle Biologics signs marketing agreement with Pharmexx - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pinnacle Biologics signs marketing agreement with Pharmexx

Pinnacle Biologics has entered into an agreement with Pharmexx to expand sales support activities in a number of countries in Western Europe. Terms of the agreement were not disclosed.

Viren Grover, vice-chairman of Pinnacle Biologics, said: “We are pleased to conclude this agreement with Pharmexx, which allows us a cost effective way to support our sales and marketing activities for Ethyol in key European markets where we believe there is upside potential.”